Drug intelligence / Profile preview

varicella vaccine + hepatitis A vaccine

Development stage
Unknown
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

The combination of varicella vaccine and hepatitis A vaccine refers to the co-administration of two separate vaccines, each targeting a different viral infection. The varicella vaccine is a live attenuated vaccine that induces immunity against the varicella-zoster virus (VZV), which causes chickenpox. It works by stimulating the immune system to produce antibodies against VZV, providing protection from future infection[1][6][8]. The hepatitis A vaccine is an inactivated (killed) virus vaccine that protects against hepatitis A virus (HAV) infection by inducing an immune response and antibody production specific to HAV[7]. Both vaccines are recommended for routine immunization in children starting at 12 months of age, with two doses required for long-term protection[3][7]. These vaccines may be administered simultaneously but as separate injections; there is no single licensed product combining both antigens into one formulation.

Brand names
OKAVAXAVAXIM 80AVAXIM80AVAXIM-80
Other names
VarV + HepA

Beyond the preview

Go deeper on varicella vaccine + hepatitis A vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on varicella vaccine + hepatitis A vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call